CD44 and hepatocellular carcinoma: A recent study also showed that SRSF1 can regulate the splicing of SRA1 in HCC, thereby promoting the transcription of CD44 and activating the ERK and AKT signaling pathways, and affecting the metastasis of HCC [28].